blank Quick help
blank Maintenance news
blank News flashes
blank Related links

Extract from the Register of European Patents

EP About this file: EP2120884

EP2120884 - PHARMACEUTICAL COMPOSITION [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  08.07.2016
Database last updated on 05.04.2025
Most recent event   Tooltip14.10.2016Lapse of the patent in a contracting state
New state(s): CH, LI
published on 16.11.2016  [2016/46]
Applicant(s)For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Inventor(s)01 / THOMAS, Ruediger
Boehringer Ingelheim GmbH CD Patents Binger Str. 173
55216 Ingelheim Am Rhein / DE
02 / MAERZ, Frieder
Boehringer Ingelheim GmbH CD Patents Binger Str. 173
55216 Ingelheim Am Rhein / DE
 [2009/48]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Application number, filing date08717753.113.03.2008
[2009/48]
WO2008EP53009
Priority number, dateEP2007010415714.03.2007         Original published format: EP 07104157
[2009/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008110599
Date:18.09.2008
Language:EN
[2008/38]
Type: A1 Application with search report 
No.:EP2120884
Date:25.11.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 18.09.2008 takes the place of the publication of the European patent application.
[2009/48]
Type: B1 Patent specification 
No.:EP2120884
Date:29.12.2010
Language:EN
[2010/52]
Search report(s)International search report - published on:EP18.09.2008
ClassificationIPC:A61K9/20
[2009/48]
CPC:
A61K9/209 (EP,US); A61K9/20 (KR); A61K31/4184 (KR);
A61K47/26 (KR); A61K9/2009 (EP,US); A61K9/2018 (EP,US); (+)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/48]
Extension statesAL14.10.2009
BA14.10.2009
MK14.10.2009
RS14.10.2009
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG[2009/48]
English:PHARMACEUTICAL COMPOSITION[2009/48]
French:COMPOSITION PHARMACEUTIQUE[2009/48]
Entry into regional phase14.10.2009National basic fee paid 
14.10.2009Designation fee(s) paid 
14.10.2009Examination fee paid 
Examination procedure14.10.2009Examination requested  [2009/48]
12.07.2010Communication of intention to grant the patent
26.10.2010Fee for grant paid
26.10.2010Fee for publishing/printing paid
Opposition(s)Opponent(s)01  26.09.2011  29.09.2011  ADMISSIBLE
Zentiva k.s.
U kabelovny 130
10237 Praha 10 / CZ
Opponent's representative
Plougmann Vingtoft a/s
Strandvejen 70
2900 Hellerup / DK
 [N/P]
deletedDeletion: Legal effect of rejection of opposition [ N /P ]
08.11.2011Invitation to proprietor to file observations on the notice of opposition
06.03.2012Reply of patent proprietor to notice(s) of opposition
29.11.2012Date of oral proceedings
20.12.2012Despatch of minutes of oral proceedings
20.12.2012Date of despatch of rejection of opposition
12.04.2016Legal effect of revocation of patent [2016/32]
18.05.2016Despatch of communication that the patent will be revoked
Appeal following opposition13.02.2013Appeal received No.  T0382/13
29.04.2013Statement of grounds filed
12.04.2016Result of appeal procedure: revocation of the patent
12.04.2016Date of oral proceedings
18.05.2016Minutes of the oral proceedings despatched
Fees paidRenewal fee
31.03.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCH29.12.2010
LI29.12.2010
MT29.12.2010
IS29.04.2011
CY13.03.2015
CZ13.03.2015
FI13.03.2015
HR13.03.2015
IE13.03.2015
LT13.03.2015
LU13.03.2015
LV13.03.2015
RO13.03.2015
SK13.03.2015
SI14.03.2015
EE31.03.2015
MC31.03.2015
NO31.03.2015
GR02.10.2015
[2016/46]
Cited inInternational search[AD]WO03059327  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [AD] 1-12 * claim - * * example - *;
 [A]WO2004028505  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-12 * claim - * * example - *;
 [A]WO2006048208  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-12 * claim - ** example - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.